291 related articles for article (PubMed ID: 11409588)
21. [Study of tubercle bacilli from persistently sputum-positive patients treated with antituberculosis drugs for long duration in 3 Shanghai districts].
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1983 Aug; 6(4):222-4. PubMed ID: 6418491
[No Abstract] [Full Text] [Related]
22. [Validity of measuring time to detect growth of M. tbc by BACTEC MGIT960 system for quantitation and prediction of mycobacterial growth].
Yamamoto Y; Fujiuchi S; Yamazaki Y; Takeda A; Nishigaki Y; Fujita Y; Fujikane T; Shimizu T
Kekkaku; 2004 Dec; 79(12):705-9. PubMed ID: 15782615
[TBL] [Abstract][Full Text] [Related]
23. Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR.
Marín M; García de Viedma D; Ruíz-Serrano MJ; Bouza E
Antimicrob Agents Chemother; 2004 Nov; 48(11):4293-300. PubMed ID: 15504855
[TBL] [Abstract][Full Text] [Related]
24. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
Aparna SB; Reddy VC; Gokhale S; Moorthy KV
Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801
[TBL] [Abstract][Full Text] [Related]
25. [Comparative bacteriological study of sputum and resected lung particles in patients with tuberculosis].
Fisher EF; Gaĭnutdinova NSh; Liadunkina MM; Mulik MI
Lab Delo; 1969; 5():298-300. PubMed ID: 4185264
[No Abstract] [Full Text] [Related]
26. [Changes in surgical treatment of pulmonary tuberculosis in recent 6 years. A comparative study between preoperative culture positive and negative cases].
Kekkaku; 1984 Aug; 59(8):467-74. PubMed ID: 6438384
[No Abstract] [Full Text] [Related]
27. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
Su WJ; Perng RP
Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151
[TBL] [Abstract][Full Text] [Related]
28. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
El-Sayed Zaki M; Goda T
Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
[TBL] [Abstract][Full Text] [Related]
29. Spoligotyping of Mycobacterium tuberculosis isolates from patients with pulmonary tuberculosis in Mumbai, India.
Kulkarni S; Sola C; Filliol I; Rastogi N; Kadival G
Res Microbiol; 2005 May; 156(4):588-96. PubMed ID: 15862459
[TBL] [Abstract][Full Text] [Related]
30. Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment.
Ramarokoto H; Randriamiharisoa H; Rakotoarisaonina A; Rasolovavalona T; Rasolofo V; Chanteau S; Ralamboson M; Cauchoix B; Rakotondramarina D
Int J Tuberc Lung Dis; 2002 Oct; 6(10):909-12. PubMed ID: 12365578
[TBL] [Abstract][Full Text] [Related]
31. [Chemotherapy of tuberculosis with controlled viability of Mycobacteria in the sputum].
Rudoĭ NM; Erkovskaia OIu
Probl Tuberk; 1978 May; (5):43-7. PubMed ID: 97658
[No Abstract] [Full Text] [Related]
32. Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy.
Desjardin LE; Perkins MD; Wolski K; Haun S; Teixeira L; Chen Y; Johnson JL; Ellner JJ; Dietze R; Bates J; Cave MD; Eisenach KD
Am J Respir Crit Care Med; 1999 Jul; 160(1):203-10. PubMed ID: 10390401
[TBL] [Abstract][Full Text] [Related]
33. HIV co-infection, CD4 cell counts and clinical correlates of bacillary density in pulmonary tuberculosis.
Mugusi F; Villamor E; Urassa W; Saathoff E; Bosch RJ; Fawzi WW
Int J Tuberc Lung Dis; 2006 Jun; 10(6):663-9. PubMed ID: 16776454
[TBL] [Abstract][Full Text] [Related]
34. [Should chemotherapy for pulmonary tuberculosis be started after the completion of pretreatment sputum examination?].
Ito K; Aono A; Yoshiyama T; Wada M; Ogata H
Kekkaku; 2005 Dec; 80(12):735-41. PubMed ID: 16447786
[TBL] [Abstract][Full Text] [Related]
35. Prediction of delayed treatment response in pulmonary tuberculosis: use of time to positivity values of Bactec cultures.
Carroll NM; Uys P; Hesseling A; Lawrence K; Pheiffer C; Salker F; Duncan K; Beyers N; van Helden PD
Tuberculosis (Edinb); 2008 Nov; 88(6):624-30. PubMed ID: 18456556
[TBL] [Abstract][Full Text] [Related]
36. [Biological characteristics of bacillary strains isolated from 250 patients of pulmonary tuberculosis dispensaries and comparison with the anatomo-clinical and epidemiological aspects].
Donateo M; Malventi M; Vernieri G
Riv Ital Ig; 1967; 27(1):67-79. PubMed ID: 4972489
[No Abstract] [Full Text] [Related]
37. Influence of pre-treatment bacillary load on treatment outcome of pulmonary tuberculosis patients receiving DOTS under revised national tuberculosis control programme.
Singla R; Singla N; Sarin R; Arora VK
Indian J Chest Dis Allied Sci; 2005; 47(1):19-23. PubMed ID: 15704711
[TBL] [Abstract][Full Text] [Related]
38. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
[TBL] [Abstract][Full Text] [Related]
39. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of BK positivity and resistance of Mycobacterium tuberculosis 1983-1986 in areas of Bosnia and Herzegovina].
Vinik LK; Konjicija A; Sutić N; Psorn-Rajs A; Matić M; Arslanagić N
Plucne Bolesti; 1988; 40(1-2):32-5. PubMed ID: 3141940
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
